<DOC>
	<DOCNO>NCT02392273</DOCNO>
	<brief_summary>This study observational study primary objective ass safety tolerability Ausanil treatment primary headache disorder . The secondary objective ass headache pain , functional outcome , time loss headache patient satisfaction Ausanil treatment .</brief_summary>
	<brief_title>A Prospective Observational Registry Primary Headache Patients Treated With Ausanil</brief_title>
	<detailed_description />
	<mesh_term>Headache</mesh_term>
	<mesh_term>Headache Disorders</mesh_term>
	<mesh_term>Headache Disorders , Primary</mesh_term>
	<criteria>Men woman age 18 80 year Primary Headache disorder per International Classification Headache Disorders11 Ausanil naive Signed date informed consent Females childbearing potential must use adequate contraception study period . Willing able comply registry requirement document headache response Known allergy Ausanil ingredient Active bronchial asthma opinion investigator would interfere use Ausanil Nasal obstruction due cause extensive nasal surgery result scar impact nasal mucosa might lead heighten sensitivity Ausanil opinion investigator . Pregnant breast feeding female History addictive behavior Any severe chronic unstable medical psychiatric condition Active nasal infection inflammation Unable unwilling provide inform consent Suffer atypical , basilar hemiplegic migraine new onset unstable .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>migraine</keyword>
	<keyword>cluster headache</keyword>
	<keyword>primary headache</keyword>
	<keyword>Ausanil</keyword>
	<keyword>capsicum annuum</keyword>
</DOC>